Rilzabrutinib was first introduced by Genzyme Corp in its drug Wayrilz on Aug 29, 2025.

Rilzabrutinib Patents

Given below is the list of patents protecting Rilzabrutinib, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)

• Argentina (AR)
• Australia (AU)
• Brazil (BR)
• Canada (CA)
• Chile (CL)
• China (CN)
• India (IN)
• Japan (JP)
• Mexico (MX)
• Paraguay (PY)
• Philippines (PH)
• Russia (RU)
• Singapore (SG)
• South Africa (ZA)
• Thailand (TH)
• United States (US)
• Uruguay (UY)
• Eurasian Patent Organization (EA)
• World Intellectual Property Organization (WO)
• Taiwan (TW)
• European Patent Office (EP)

Patent Category : All

• All
• Combination
• Compound
• Device
• Dosage Regimen
• Formulation
• Other Forms
• Polymorph
• Process
• Use Method

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Wayrilz	US11708370		Feb 20, 2041	Genzyme Corp
Wayrilz	US12178818		Oct 13, 2040	Genzyme Corp
Wayrilz	US8940744		Sep 06, 2033	Genzyme Corp
Wayrilz	US9266895		Sep 06, 2033	Genzyme Corp
Wayrilz	US9994576		Sep 06, 2033	Genzyme Corp
Wayrilz	US9580427		Mar 01, 2033	Genzyme Corp

Add above patents to watchlist

Rilzabrutinib's Family Patents

Unlock Global Patents

Rilzabrutinib Generic API Manufacturers

Given below is the list of companies who have filed for Rilzabrutinib generic, along with the locations of their manufacturing plants worldwide.